Evidence map›Paper›PMID 29547639›Full record

ArticlePLoS pathogens2018

Interleukin-4 activated macrophages mediate immunity to filarial helminth infection by sustaining CCR3-dependent eosinophilia.

Joseph D Turner, Nicolas Pionnier, Julio Furlong-Silva, Hanna Sjoberg, Stephen Cross, Alice Halliday, Ana F Guimaraes, Darren A N Cook, Andrew Steven, Nico Van Rooijen and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. NKp46Frontiers in immunology · 2022
    Article
  12. Trickle infection withFrontiers in immunology · 2022
    Article
  13. Advances in preclinical platforms ofFrontiers in tropical diseases · 2021
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Joseph D TurnerResearch Centre for Drugs & Diagnostics, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.ORCID 0000-0002-2185-5476
Nicolas PionnierResearch Centre for Drugs & Diagnostics, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.ORCID 0000-0002-2379-4945
Julio Furlong-SilvaResearch Centre for Drugs & Diagnostics, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.ORCID 0000-0002-3313-8650
Hanna SjobergResearch Centre for Drugs & Diagnostics, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.ORCID 0000-0003-1948-6779
Stephen CrossResearch Centre for Drugs & Diagnostics, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.ORCID 0000-0002-8806-9891
Alice HallidayResearch Centre for Drugs & Diagnostics, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.ORCID 0000-0001-8183-1110
Ana F GuimaraesResearch Centre for Drugs & Diagnostics, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.ORCID 0000-0001-6651-5136
Darren A N CookResearch Centre for Drugs & Diagnostics, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Andrew StevenResearch Centre for Drugs & Diagnostics, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.ORCID 0000-0001-6395-562X
Nico Van RooijenVU University Medical Center, Department of Molecular Cell Biology and Immunology, Amsterdam, Netherlands.
Judith E AllenFaculty of Biology, Medicine & Health, University of Manchester, Manchester, United Kingdom.ORCID 0000-0002-3829-066X
Stephen J JenkinsMRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0002-0233-5424
Mark J TaylorResearch Centre for Drugs & Diagnostics, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.ORCID 0000-0003-3396-9275
Liverpool School of Tropical Medicine · GBAmsterdam UMC Location Vrije Universiteit Amsterdam · NLCentre for Inflammation Research · GBUniversity of Manchester · GB

Funding

Medical Research Council MR/K01207X/1Medical Research Council MR/K01207X/2Medical Research Council MR/L018756/1
6 · The paper itself

Abstract

Eosinophils are effectors in immunity to tissue helminths but also induce allergic immunopathology. Mechanisms of eosinophilia in non-mucosal tissues during infection remain unresolved. Here we identify a pivotal function of tissue macrophages (Mϕ) in eosinophil anti-helminth immunity using a BALB/c mouse intra-peritoneal Brugia malayi filarial infection model. Eosinophilia, via C-C motif chemokine receptor (CCR)3, was necessary for immunity as CCR3 and eosinophil impairments rendered mice susceptible to chronic filarial infection. Post-infection, peritoneal Mϕ populations proliferated and became alternatively-activated (AAMϕ). Filarial AAMϕ development required adaptive immunity and interleukin-4 receptor-alpha. Depletion of Mϕ prior to infection suppressed eosinophilia and facilitated worm survival. Add back of filarial AAMϕ in Mϕ-depleted mice recapitulated a vigorous eosinophilia. Transfer of filarial AAMϕ into Severe-Combined Immune Deficient mice mediated immunological resistance in an eosinophil-dependent manner. Exogenous IL-4 delivery recapitulated tissue AAMϕ expansions, sustained eosinophilia and mediated immunological resistance in Mϕ-intact SCID mice. Co-culturing Brugia with filarial AAMϕ and/or filarial-recruited eosinophils confirmed eosinophils as the larvicidal cell type. Our data demonstrates that IL-4/IL-4Rα activated AAMϕ orchestrate eosinophil immunity to filarial tissue helminth infection.

Indexed as

AnimalsAntineoplastic AgentsBrugia malayiCytokinesEosinophiliaFemaleFilariasisInterleukin-4MacrophagesMaleMiceMice, Inbred BALB CMice, SCIDReceptors, CCR3Antineoplastic AgentsCcr3 protein, mouseCytokinesInterleukin-4Receptors, CCR3

Identifiers

PMID29547639
PMCPMC5874077
OpenAlexW2794295073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.